Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Oncobiologics, a Cranbury, New Jersey-based biopharmaceutical company developing monoclonal antibody (mAb) biosimilars, has launched a contract development and manufacturing (CDMO) business. It further formed a master services agreement (MSA) with...

Glenmark Pharmaceuticals, a Mumbai, India-headquartered pharmaceutical company, has received approval of its first abbreviated new drug application by the US Food & Drug Administration (FDA) made at the company’s new manufacturing facility in...

Pacira Pharmaceuticals, a Parsippany, New Jersey-based specialty pharmaceutical company, and Nuance Biotech, a Shanghai, China-based specialty pharmaceutical company, have formed an agreement to develop and commercialize Exparel (bupivacaine...

Roche has agreed to acquire full ownership of Foundation Medicine’ a Cambridge, Massachusetts-based molecular information company, by acquiring the outstanding shares not already owned by Roche for approximately $2.4 billion. Roche now owns more...

Alexion Pharmaceuticals, a New Haven, Connecticut-based pharmaceutical company, and Complement Pharma, a pharmaceutical company headquartered in Amsterdam, the Netherlands, have partnered to co-develop Complement Pharma’s preclinical C6 complement...

A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Roche, AbbVie, AstraZeneca, and Amgen. Editor's Note: This article was updated on a continuous basis for news announced from Wednesday June...